Fact.MR – Anticoagulants Market Analysis By Drug Class (Factor X Inhibitor (NOAC/DOAC) Anticoagulants, Heparin Anticoagulants, Direct Thrombin Inhibitor Anticoagulants, Vitamin K Antagonist Anticoagulants), By Route of Administration, By Indication - Global Market Insights 2021 to 2031

Anticoagulants Market is expected to register a CAGR of nearly 8% during the forecast period, 2020-2026. Factor XA inhibitors dominate the drug class.